Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2024

1.6

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

2.0

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.360

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.754

Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

Time to first decision

33 days

View more metrics

Open Access Option

Journal Information

Back to article

Statistics

Follow this link to access the full text of the article

Original article

Human leukocyte antigen immunization in transfusion-dependent Moroccan patients with beta-thalassemia major: prevalence and risk factors

Sanae Ouadghiria,b,

Corresponding author

s.ouadghiri@um5s.net.ma

Corresponding author at: Blood Transfusion, Children's Hospital, Ibn Sina University Hospital, Rabat, Morocco.

, Kaoutar El Morabita, Naoual Elansaric, Ouafae Atoufa,b, Maria Elkababric,b, Laila Hessissenc,b, Malika Essakallia,b

a Blood Transfusion, Ibn Sina University Hospital, Rabat, Morocco

b Faculty of Medicine and Pharmacy, Mohamed V University, Rabat, Morocco

c Pediatric Oncology center of the children's Hospital, Ibn Sina University Hospital, Rabat, Morocco

Read

4395

Times
was read the article

1102

Total PDF

3293

Total HTML

Share statistics

Facebook

Bluesky

E-mail

Article information

ISSN: 25311379
Original language: English

DOI:10.1016/j.htct.2023.03.023

The statistics are updated each day

Year/Month	Html	Pdf	Total
2026 3	45	13	58
2026 2	123	42	165
2026 1	265	89	354
2025 12	290	107	397
2025 11	257	47	304
2025 10	136	40	176
2025 9	148	23	171
2025 8	109	16	125
2025 7	111	33	144
2025 6	83	23	106
2025 5	136	16	152
2025 4	77	19	96
2025 3	106	18	124
2025 2	70	21	91
2025 1	79	26	105
2024 12	112	25	137
2024 11	135	47	182
2024 10	138	35	173
2024 9	106	33	139
2024 8	79	33	112
2024 7	64	27	91
2024 6	87	30	117
2024 5	115	28	143
2024 4	66	18	84
2024 3	47	28	75
2024 2	33	24	57
2024 1	36	24	60
2023 12	27	22	49
2023 11	45	37	82
2023 10	32	28	60
2023 9	27	29	56
2023 8	28	25	53
2023 7	21	10	31
2023 6	37	31	68
2023 5	23	35	58

Show all

Follow this link to access the full text of the article

Statistics

Subscribe to our newsletter